Why are biofilms particularly challenging in clinical infections?

• A. They mutate faster leading to susceptibility
• B. They are easily eradicated by standard antibiotics
• C. They protect microbes from antibiotics and immune defenses and promote persistent infections
• D. They only form in lab settings

Answer: (C)

Biofilms form a protective, slime-like matrix that encases microbes on surfaces, creating a structured community. This matrix slows or limits antibiotic penetration, and cells inside often become slow-growing or dormant, making many antibiotics less effective since they target actively dividing bacteria. The dense community also creates gradients of nutrients and oxygen, fostering persister cells that can survive treatment and reseed infection once therapy ends. In addition, the biofilm shields microbes from immune defenses; phagocytes struggle to reach the cells, and immune factors can be less effective or neutralized within the matrix. Close proximity within a biofilm facilitates gene exchange, potentially spreading resistance traits. All of these factors contribute to chronic, hard-to-eradicate infections, especially on implanted devices or persistent wounds.